Cardalis Medium 5mg/40mg 30 Tabs POM
Item No. 89782
For the treatment of congestive heart failure caused by chronic degenerative valvular disease in dogs. Cardalis is a veterinary medicine that contains two active substances, benazepril hydrochloride and spironolactone. It is available as chewable tablets (2.5 mg/20 mg, 5 mg/40 mg and 10 mg/80 mg).
Description
For the treatment of congestive heart failure caused by chronic degenerative valvular disease in dogs. Cardalis is a veterinary medicine that contains two active substances, benazepril hydrochloride and spironolactone. It is available as chewable tablets (2.5 mg/20 mg, 5 mg/40 mg and 10 mg/80 mg). Cardalis is used to treat dogs with congestive heart failure. Cardalis is used for congestive heart failure caused by long-term damage to the heart valves.
The tablets are given to the dog once a day with food at a dose of 0.25 mg benazepril hydrochloride and 2 mg spironolactone per kilogram bodyweight. The tablets may either be mixed with a small amount of food offered to the dog just before the main meal, or with the meal itself.
The tablets are given to the dog once a day with food at a dose of 0.25 mg benazepril hydrochloride and 2 mg spironolactone per kilogram bodyweight. The tablets may either be mixed with a small amount of food offered to the dog just before the main meal, or with the meal itself.
Specifications
- Species
- Companion Animal
- Business Unit
- Small Animal
- HPRA SPC Link
- https://www.ema.europa.eu/en/documents/product-information/cardalis-epar-product-information_en.pdf
- Legal category
- POM
- Active/Ingredient(s)
- benazepril spironolactone
Cardalis Medium 5mg/40mg 30 Tabs POM
Item No. 89782
For the treatment of congestive heart failure caused by chronic degenerative valvular disease in dogs. Cardalis is a veterinary medicine that contains two active substances, benazepril hydrochloride and spironolactone. It is available as chewable tablets (2.5 mg/20 mg, 5 mg/40 mg and 10 mg/80 mg).
Description
For the treatment of congestive heart failure caused by chronic degenerative valvular disease in dogs. Cardalis is a veterinary medicine that contains two active substances, benazepril hydrochloride and spironolactone. It is available as chewable tablets (2.5 mg/20 mg, 5 mg/40 mg and 10 mg/80 mg). Cardalis is used to treat dogs with congestive heart failure. Cardalis is used for congestive heart failure caused by long-term damage to the heart valves.
The tablets are given to the dog once a day with food at a dose of 0.25 mg benazepril hydrochloride and 2 mg spironolactone per kilogram bodyweight. The tablets may either be mixed with a small amount of food offered to the dog just before the main meal, or with the meal itself.
The tablets are given to the dog once a day with food at a dose of 0.25 mg benazepril hydrochloride and 2 mg spironolactone per kilogram bodyweight. The tablets may either be mixed with a small amount of food offered to the dog just before the main meal, or with the meal itself.
Specifications
- Species
- Companion Animal
- Business Unit
- Small Animal
- HPRA SPC Link
- https://www.ema.europa.eu/en/documents/product-information/cardalis-epar-product-information_en.pdf
- Legal category
- POM
- Active/Ingredient(s)
- benazepril spironolactone